Michael S Aberman - Net Worth and Insider Trading
Michael S Aberman Net Worth
The estimated net worth of Michael S Aberman is at least $19 Million dollars as of 2024-09-21. Michael S Aberman is the SVP Strategy Investor Relation of Regeneron Pharmaceuticals Inc and owns about 16,946 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $19 Million. Details can be seen in Michael S Aberman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael S Aberman has not made any transactions after 2017-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael S Aberman
Michael S Aberman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael S Aberman owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .
Click here to see the complete history of Michael S Aberman’s form 4 insider trades.
Insider Ownership Summary of Michael S Aberman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2017-06-22 | VP & Strat and Invest Relations |
Michael S Aberman Latest Holdings Summary
Michael S Aberman currently owns a total of 1 stock. Michael S Aberman owns 16,946 shares of Regeneron Pharmaceuticals Inc (REGN) as of June 22, 2017, with a value of $19 Million.
Latest Holdings of Michael S Aberman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2017-06-22 | 16,946 | 1,144.90 | 19,401,475 |
Holding Weightings of Michael S Aberman
Michael S Aberman Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael S Aberman has made a total of 0 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 2,269 shares on June 22, 2017, which brought Michael S Aberman around $1 Million.
Insider Trading History of Michael S Aberman
- 1
Michael S Aberman Trading Performance
Michael S Aberman Ownership Network
Michael S Aberman Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Michael S Aberman is the VP & Strat and Invest Relations of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Michael S Aberman made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 9,914 shares made by Marion Mccourt , a net sale of 1,500 shares made by Arthur F Ryan , and a net sale of 9,158 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 36,273 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 36,273 shares. During the past 18 months, 326,467 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 326,467 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Michael S Aberman Mailing Address
Above is the net worth, insider trading, and ownership report for Michael S Aberman. You might contact Michael S Aberman via mailing address: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown Ny 10591.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
